FOLH1 and liver failure: On the upside, it could be advantageous to have PSMA radiotracers with different clearance profiles from previous PSMA radiotracers to adapt according to patient comorbidities (e.g., renal failure and liver failure) and previous irradiation (e.g., pelvic radiotherapy).